Skip to the page content
Your donations
Passes our checks

Davos Alzheimers Collaborative Inc

EIN 86-1884515 · Wayne, PA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthGood70 out of 100GovernanceStrong93 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

DAC IS LEADING THE LARGEST GLOBAL RESPONSE OF ITS KIND, DRIVING SCIENTIFIC DISCOVERY AND ALIGNING HEALTH SYSTEMS TO HELP PEOPLE WORLDWIDE, INCLUDING THOSE IN LOW RESOURCED ENVIRONMENTS LEFT OUT OF PREVIOUS EFFORTS TO FIGHT ALZHEIMER'S. (SEE SCHEDULE O)WE ARE COMMITTED TO TRANSFORMING ALZHEIMER'S RESEARCH, PREVENTION AND CARE THROUGH PROVEN PRIVATE-PUBLIC MODELS, SUCH AS GAVI, CEPI AND THE GLOBAL FUND.

Income
$12.5 million
Spending
$16.1 million
Spent on programs
92%
Reserves
3 months of spending
Largest source of income
donations and private grants, 98%
Employees
0
Volunteers
3

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Good: 70 out of 100. Higher than 51% of charities in its peer group (diseases, $10m to $100m).

  • Reserves

    20 of 35

    Spendable reserves would cover 3.0 months of spending.

  • Debt

    20 of 20

    It owes 7% of what it owns.

  • Living within its means

    0 of 15

    Spending exceeded income by 29% of income.

  • Income trend

    15 of 15

    Income rose 38% on the year before.

  • Spending floor

    15 of 15

    92% of spending went to programs and raising each dollar of donations cost 6 cents.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 93 out of 100. Higher than 23% of charities in its peer group (diseases, $10m to $100m).

  • Independent board

    18 of 25

    2 of 3 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (3)
  1. $13.2 million spent. THE DAVOS ALZHEIMER'S COLLABORATIVE'S SYSTEM PREPAREDNESS PROGRAM AIMS TO STRENGTHEN HEALTHCARE SYSTEMS' ABILITY TO IDENTIFY AND ADDRESS ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) EARLY. KEY INITIATIVES INCLUDE THE EARLY DETECTION FELLOWSHIP, WHICH OFFERS TECHNICAL ASSISTANCE AND FUNDING TO HEALTHCARE ORGANIZATIONS (HCOS) TO IMPLEMENT THE EARLY DETECTION BLUEPRINT, FOSTERING COLLABORATION AMONG SELECTED SITES TO OVERCOME BARRIERS AND ENHANCE EARLY DETECTION. THE PROGRAM ALSO INCLUDES THE BRAIN HEALTH NAVIGATOR INITIATIVE, DESIGNED TO PILOT A BRAIN HEALTH NAVIGATOR MODEL IN SIX HCOS TO SUPPORT TIMELY CARE FOR PATIENTS WITH COGNITIVE DECLINE. ADDITIONALLY, THE ACCURATE DIAGNOSIS PROGRAM AIMS TO INCREASE THE USE OF NEW DIAGNOSTIC TOOLS, HELPING HEALTHCARE SYSTEMS ADOPT MORE EFFECTIVE METHODS FOR DIAGNOSING AD/ADRD. THESE EFFORTS ARE SUPPORTED BY SIGNIFICANT FUNDING AND ARE INTENDED TO IMPROVE SYSTEM PREPAREDNESS THROUGH OUTREACH, TRAINING, AND THE CREATION OF PRACTICAL TOOLKITS FOR HEALTHCARE PROVIDERS.OVERALL, OUTPUTS INCLUDE PEER-REVIEWED PUBLICATIONS, SYMPOSIUMS, POLICY COMMUNICATIONS, AND AN OPEN-ACCESS "BLUEPRINT" FOR AD/ADRD EARLY DETECTION AND SYSTEM PREPAREDNESS. DAC ALSO COLLABORATES WITH OTHER ORGANIZATIONS TO ADDRESS COMMON BARRIERS AND PROMOTE BEST PRACTICES ACROSS HEALTH SYSTEMS.
  2. $1.7 million spent. THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL COHORT DEVELOPMENT PROGRAM FOCUSES ON BUILDING A DIVERSE AND SUSTAINABLE NETWORK OF COHORTS TO ADVANCE ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) RESEARCH. THIS INCLUDES PARTNERSHIPS SUCH AS THE COLLABORATION WITH AGA KHAN UNIVERSITY IN NAIROBI, KENYA, WHERE COGNITIVE TESTS, SALIVA-BASED POLYGENIC RISK SCORES, AND DIGITAL COGNITIVE ASSESSMENTS ARE BEING VALIDATED IN EAST AFRICAN POPULATIONS TO CREATE A CLINICAL TRIAL-READY COHORT. IN SOUTH KOREA, DAC HAS ACQUIRED BLOOD SAMPLES FROM 300 PARTICIPANTS IN A HIGHLY CHARACTERIZED COHORT, ADVANCING THE VALIDATION OF BLOOD-BASED BIOMARKERS (BBMS) FOR GLOBAL USE. THE PROJECT ALSO INCLUDES ACCESS TO 1,000 BLOOD SAMPLES FROM A LONG-STANDING COHORT IN THE LATAM/CARIBBEAN REGION FOR AD BLOOD BIOMARKER VALIDATION, AS WELL AS A LARGE-SCALE CLINICAL TRIAL RECRUITMENT EFFORT IN THE DOMINICAN REPUBLIC, WITH OVER 14,000 PARTICIPANTS ACROSS URBAN AND RURAL SETTINGS.FURTHER EXPANDING GLOBAL RESEARCH, DAC IS DEVELOPING SCALABLE APPROACHES IN EGYPT FOR EARLY DETECTION, MONITORING, AND RISK REDUCTION OF AD, WHILE IN INDIA, THE "EYE-DEA STUDY" IS USING CATARACT SURGERY CLINICS TO ASSESS OCULAR, SPEECH, AND OLFACTORY BIOMARKERS RELATED TO COGNITIVE IMPAIRMENT. IN CHILE, DAC IS COLLECTING A WIDE RANGE OF DATA FROM A 9,000-PERSON COHORT TO GENERATE LOCAL VALIDATION DATA FOR BLOOD BIOMARKERS AND DIGITAL COGNITIVE ASSESSMENTS, PARTICULARLY FOCUSING ON THE IMPACT OF PESTICIDE USE AND EXPOSURE TO NEUROTOXINS. THESE EFFORTS ARE HELPING TO ENSURE THAT AD RESEARCH IS INCLUSIVE OF DIVERSE POPULATIONS AND ADAPTABLE TO LOCAL SETTINGS, WITH THE AIM OF IMPROVING EARLY DETECTION, DIAGNOSIS, AND TREATMENT ON A GLOBAL SCALE.
  3. THE DAVOS ALZHEIMER'S COLLABORATIVE'S GLOBAL CLINICAL TRIAL PROGRAM IS MAINTAINING A NETWORK OF MORE THAN 30 EUROPEAN SITES ORGANIZED TO ACCELERATE STUDIES AND IMPLEMENT NOVEL TRIAL DESIGNS. THIS EFFORT IS PART OF DAC'S BROADER GOAL TO BUILD INFRASTRUCTURE FOR FUTURE PHARMACOLOGICAL AND NON-PHARMACOLOGICAL TRIALS GLOBALLY. THROUGH THE GLOBAL COHORT DEVELOPMENT PROGRAM, DAC IS WORKING TO CREATE CLINICAL TRIAL-READY POPULATIONS BY 2026, ENSURING THAT DIVERSE AND WELL-CHARACTERIZED COHORTS ARE PREPARED FOR BOTH TYPES OF INTERVENTIONS. THIS WILL EXPAND OPPORTUNITIES FOR GLOBAL CLINICAL TRIALS, ENHANCING THE ABILITY TO TEST NEW TREATMENTS AND APPROACHES IN ALZHEIMER'S DISEASE (AD) AND RELATED DEMENTIAS (ADRD) ACROSS VARIED POPULATIONS AND SETTINGS.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 2021.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.